n-omega-nitro-l-arginine methyl ester
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 8, 2018 (NCT03680573)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Nitric-oxide synthase, brainINHIBITOR
NOS1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- n-omega-nitro-l-arginine methyl ester
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06159608 | Early Phase 1 (Phase 1) | Nov 30, 2024 | University of Iowa |
| NCT03679780 | Phase 1 | Oct 1, 2018 | University of Texas, Arlington |
| NCT03680573 | Phase 1 | Jan 8, 2018 | University of Texas, Arlington |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Texas, Arlington | Academic/Hospital | 2 | 2 | 1 | 2018 |
| University of Iowa | Academic/Hospital | 1 | 1 | 1 | 2024 |
2 organizations
Page 1 / 1